Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_assertion type Assertion NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_head.
- NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_assertion wasGeneratedBy ECO_0000203 NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_provenance.
- NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_assertion wasDerivedFrom befree-20150227 NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_provenance.
- NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_assertion SIO_000772 22745587 NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_provenance.
- NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_assertion evidence source_evidence_literature NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_provenance.
- NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_assertion description "[Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_provenance.